Lower airway probiotics and methods of use for protection and treatment of respiratory disease

Abstract

In certain embodiments, the present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a lower airway probiotic composition comprising a physiological solution and a single candidate probiotic (CP) population, wherein the CP is CP4, CP7, CP8, CP9, CP13, CP17, CP18, CP19, CP20, or CP26. In certain embodiments, the present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a lower airway probiotic composition, wherein the lower airway probiotic composition comprises at least two candidate probiotic (CP) populations CP8 and CP19, CP20 and CP17, or CP19 and CP26 Also provided are kits and methods of using these pharmaceutical compositions.

Dependencies are inferred from the claim text.